R&D

Imbria touts PhII good fortune in hypertrophic cardiomyopathy, including gasoline to total efficacy profile

Imbria Pharmaceuticals’ partial fatsty acid oxidation inhibitor improved outis available in Section II non-obstructive hyconsistent withtrophic automotivediomyopathy patients, with the compathe big apple now noting that the asset’s efficacy may just bode

November 8, 2023

OpenAI

Retrospective research displays possible for GLP-1s to regard blood clots

SAN DIEGO — As researchers explore extra potential benesuits of GLP-1 medicines, a brand new retrospective find out about is suggesting the drug magnificence’ potential to regard venous … Signal as much

December 10, 2024

Health

In marvel, learn about suggests Covid mRNA vaccines might spice up most cancers immunotherapy efficacy

The mRNA-based Covid vaccines utilized by hundreds of millions of people might professionalvide an unexpected beneare compatible to a couple cancer patients, significantly improving survival when given … Signal as much as

September 16, 2024

Health

Rivus posts a win for its experimental weight problems drug in middle failure sufferers

Rivus Pharmaceuticals’ exin line withimalestal automobilediometabolic drug, HU6, nailed a mid-stage trial in overweight patients with middle failure, to finding that patients notched a statistically significant reduction in … Signal as much

August 14, 2024

Health

Autoimmune CAR-Ts are beneath the microscope after Cabaletta’s protection factor in lupus

Eyes are on CAR-T therapy clinical trials in autoimmune diseases for potentially extra serious facet effects, after Cabaletta’s Bio’s candidate was once connected with a prime … Signal as much as learn

August 9, 2024

Health

KRAS most cancers drug eased signs of infrequent and severe blood vessel situation in two sufferers, new learn about displays

The advertvent of recent targeted oncology therapies might beneare compatible extra than simply cancer patients. Two patients with severe arteriovenous malformations — an ultra-rare condition the place a … Signal as much

July 18, 2024

Health

Scientists unveil new technique to make huge adjustments to genes, and no CRISPR is needed

Join unfastened to learn a restricted choice of articles each and every month.Pick out what newsletters get delivered on your inbox each and every week. Biopharma ENDPOINTS NEWS Day-to-day at 11:30 AM

June 26, 2024

Science

Novo reviews ‘in reality tough’ aerobic, demise possibility relief for semaglutide in kidney illness

Novo Nordisk’s semaglutide reduce the chance of major automotivediovascular occasions and demise from multiple causes in a Segment 3 learn about involving patients with kind 2 diabetes and chronic childney disease, constructing

May 24, 2024

Health

Throughout two medical trials, gene treatment restores listening to in kids deaf since beginning: #ASGCT24

BALTIMORE — Ten out of eleven children who had been born deaf can now listen after receiving a gene therapy from a Shanghai biotech, acwireing to new results shared Thursday. The children

May 10, 2024

Health

Instructional trial suggests modest GLP-1 impact in Parkinson’s illness, however questions stay

New data from a French academic trial published within the New England Journal of Medicine on Wednesday suggest the potential for deal withing Parkinson’s disease with a GLP-1 agonist. The impact to

April 5, 2024

Health

With GIP, weight problems analysis is at odds

Over a decade in the past, a gaggle of researchers led by means of two diabetes experts, Richard DiMarchi and Matthias Tschöp, published a landmark pain step with in mice that suggested

March 28, 2024

Health

1 2 3 Next

R&D

Imbria touts PhII good fortune in hypertrophic cardiomyopathy, including gasoline to total efficacy profile

Retrospective research displays possible for GLP-1s to regard blood clots

In marvel, learn about suggests Covid mRNA vaccines might spice up most cancers immunotherapy efficacy

Rivus posts a win for its experimental weight problems drug in middle failure sufferers

Autoimmune CAR-Ts are beneath the microscope after Cabaletta’s protection factor in lupus

KRAS most cancers drug eased signs of infrequent and severe blood vessel situation in two sufferers, new learn about displays

Scientists unveil new technique to make huge adjustments to genes, and no CRISPR is needed

Novo reviews ‘in reality tough’ aerobic, demise possibility relief for semaglutide in kidney illness

Throughout two medical trials, gene treatment restores listening to in kids deaf since beginning: #ASGCT24

Instructional trial suggests modest GLP-1 impact in Parkinson’s illness, however questions stay

With GIP, weight problems analysis is at odds

Recent Posts

Categories

Suggestions

R&D

Recent Posts

Categories